Image pharmaphorum Editor Digital NHS IT glitch ‘caused deaths by cancelling cancer screening’ Health secretary Jeremy Hunt to launch inquiry News BMS strikes three-year cancer R&D deal with Flatiron Bristol-Myers Squibb has struck a three-year with Flatiron Health that aims to make cancer R&D more efficient and patient-focused. News AZ's Tagrisso looks set for first-line lung cancer label in ... Expanded label likely in coming weeks News SMEs: the next generation of pharma The future beyond blockbusters: more precise, more patient-centred and more SME-led. Load more results
Digital NHS IT glitch ‘caused deaths by cancelling cancer screening’ Health secretary Jeremy Hunt to launch inquiry
News BMS strikes three-year cancer R&D deal with Flatiron Bristol-Myers Squibb has struck a three-year with Flatiron Health that aims to make cancer R&D more efficient and patient-focused.
News AZ's Tagrisso looks set for first-line lung cancer label in ... Expanded label likely in coming weeks
News SMEs: the next generation of pharma The future beyond blockbusters: more precise, more patient-centred and more SME-led.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.